Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Director Higuchi John W. bought 123,000 shares of Lipocine Inc. (NASDAQ: LPCN) on April 6, 2026, for $2.05 per share, a transaction totaling $252,149. The purchase brings his direct holdings to 163,797 shares. The transaction coincides with the stock trading close to a 52-week low, and follows Phase 3 trial results for LPCN 1154 that missed the pri…
John W. Schlosser, Vice President and President, Terminals at Kinder Morgan, sold 6,166 shares of Class P common stock on April 6, 2026, for roughly $203,071 under a pre-established 10b5-1 plan. The disposal occurred while KMI shares trade near a 52-week high and amid a patchwork of recent analyst revisions and corporate pipeline developments.
Fox Factory (FOXF) is trading well below its 52-week high after a difficult earnings stretch and a hit to reported EPS. The company's niche in performance suspension, OEM partnerships, and growing UTV/aftermarket markets — plus recent brand deals — argue for a multi-quarter recovery. Buy on weakness with a disciplined stop and a 180-trading-day tar…
RA Capital Management and affiliated parties sold a combined 842,282 shares of Vor Biopharma Inc. (NASDAQ: VOR) in multiple transactions on April 2 and April 6, 2026, generating proceeds of about $14.5 million. The disposals took place as VOR's share price traded with notable volatility and followed a period of fresh financing and clinical mileston…
Air New Zealand announced a further reduction in services across May and June and said it will increase fares, citing a sharp rise in jet fuel costs tied to the ongoing Iran war. The carrier said the latest consolidation will impact around 4% of flights and about 1% of passengers over the two-month period, and that affected customers will be inform…
Magnetar Financial LLC, a roughly 10% holder of Wheeler Real Estate Investment Trust, Inc. (NASDAQ: WHLR), sold a total of 23,088 shares of Wheeler common stock between April 1 and April 6, 2026, for approximately $21,460. The trades came in three blocks at weighted average prices from $0.9234 to $0.9466 per share. Wheeler continues to adjust its c…
Broadcom has agreed to partner with Google to develop and supply future generations of custom artificial intelligence chips and other components for Google’s next-generation AI racks through 2031. In a related arrangement, Broadcom will provide Anthropic with access to roughly 3.5 gigawatts of AI computing capacity that will draw on Google’s AI pro…
Lipocine Inc. (NASDAQ:LPCN) Chief Executive Officer Mahesh V. Patel purchased 25,000 shares of company stock on April 6, 2026 at $2.03 per share, totaling $50,749. The transaction occurs as the share price trades close to a 52-week low of $1.81 after a 74% decline over the prior week. Separately, Lipocine disclosed that its postpartum depression dr…
A 60-day waiver of the Jones Act that began March 17 allowing foreign-flagged vessels to move fuel between U.S. ports has so far not increased domestic oil shipments, according to trade data and industry commentary. Instead, U.S. fuel exports surged to a record as refiners and shipowners capitalized on stronger international pricing and long-haul f…
Apogee (APOG) trades at an attractive multiple relative to cash flow and sales with a market cap of roughly $717M, EV/EBITDA ~8 and free cash flow of $67M. Recent weakness reflects cyclical headwinds and restructuring charges, but improving margins from cost-cutting and a 3%+ dividend make a measured long trade compelling. Entry $33.33, stop $30.50…
Arve Hanstveit, a director at Energy Recovery, Inc. (NASDAQ: ERII), sold 165,292 shares on April 2, 2026, for roughly $1.67 million at $10.14 per share. The disposition was executed by a broker without Hanstveit's instruction to satisfy a margin call on shares pledged as collateral. The transaction comes as Energy Recovery reported fourth-quarter 2…
Guardant Health is trading off a recent high but has tangible catalysts — including a new FDA companion diagnostic approval and expanding market tailwinds for liquid biopsy — that justify a tactical long. This trade plan targets a mid-term rebound to $110 while capping downside at $82, using the current weakness as an entry.
Paul L. Alpern, Vice President and General Counsel of Arteris, Inc. (NASDAQ: AIP), sold 3,649 shares of common stock on April 2, 2026, in transactions executed at $17.6528 per share, totaling $64,415. The disposals were carried out to satisfy tax obligations tied to the release of restricted stock units and were not described as discretionary trade…
Planet Labs PBC President and CFO Ashley F. Johnson sold 200,000 Class A shares on April 2, 2026, for roughly $7,020,218, and on April 6, 2026 moved 525,708 shares into The Johnson Joint Revocable Trust. The company also reported stronger-than-expected fourth-quarter fiscal 2026 results, received mixed analyst target revisions, announced a Pelican …
Lightwave Logic director Thomas M. Connelly Jr. sold 9,000 shares of common stock on April 6, 2026, for $8.52 per share, yielding $76,680. The sale, disclosed on a Form 4, was made to meet tax-withholding obligations tied to restricted stock unit vestings on March 31, 2026. The move comes as Lightwave Logic's stock has climbed 786% over the past ye…
Charles Janac, president and chief executive of Arteris, Inc. (NASDAQ:AIP), sold a combined $375,438 of company stock in two transactions on April 2 and April 6. The April 2 sales covered tax obligations from restricted stock units, while the April 6 sale occurred under a 10b5-1 plan adopted March 5, 2025. The moves coincide with a steep share-pric…
Arteris, Inc. CFO Nicholas B. Hawkins disposed of 5,870 shares on April 2, 2026, in multiple transactions disclosed on a Form 4, raising $85,969. The sales were reported as tax-covering actions tied to the vesting of restricted stock units. Arteris recently posted better-than-expected fourth-quarter 2025 results, while InvestingPro flags the stock …
Arteris, Inc. (NASDAQ: AIP) Chief Operating Officer Laurent R. Moll sold a combined $127,182 of company shares on April 2 and April 6, with the April 2 transactions intended to cover tax liabilities tied to restricted stock units and the April 6 sale conducted under a prearranged 10b5-1 plan. The moves come as Arteris shares trade near a 52-week hi…
Iridium Communications Inc. (NASDAQ: IRDM) reported two insider sales by Timothy Kapalka, Chief Administrative Officer of Iridium Satellite LLC, totaling 5,833 shares and $184,909 in proceeds. The sales occurred on April 2 and April 6 at $31.00 and $33.00 per share, respectively. The disclosures arrive while IRDM trades near its 52-week high follow…
NIO combines a sharp recovery in deliveries, a first quarterly profit, and improving technicals with elevated short interest. I favor a mid-term long trade at current levels ($6.24) to capture upside from continued delivery momentum and potential short-covering, while keeping a disciplined $5.00 stop to limit downside.
OpenAI has formally requested that the attorneys general of California and Delaware consider investigating Elon Musk and his associates for what the company described as "improper and anti-competitive behavior." The appeal comes as a jury trial between the parties is set to begin this month, stemming from a 2024 lawsuit filed by Musk that accuses O…
Beam Therapeutics Chief Medical Officer Amy Simon sold 6,700 shares on April 1, 2026, in an automated transaction to satisfy tax withholding tied to vesting restricted stock units. The sale, executed under a Rule 10b5-1 trading plan adopted May 19, 2023, totaled $164,686. Beam shares trade near $24.23 amid recent clinical data releases that have le…
Altimmune director John Gill purchased 9,200 shares of company stock on April 6, 2026, paying between $3.4050 and $3.4080 per share for a total of $31,349. The transaction occurred while the shares have climbed more than 15% in the prior week. The company recently posted fourth-quarter 2025 results that missed expectations on both EPS and revenue, …
Beam Therapeutics Inc. CEO John M. Evans sold 30,078 shares on April 1, 2026, generating about $739,317 to satisfy tax-withholding tied to the vesting of restricted stock units. The sale, executed under a Rule 10b5-1 plan adopted in May 2023, leaves Evans with direct and indirect holdings exceeding 1.15 million shares. Separately, Beam published Ph…
Lands’ End CFO and Treasurer Bernard Louis McCracken III sold 3,362 shares of common stock on April 1, 2026, at $45 per share, totaling $151,290, while exercising and receiving additional shares at no cost. The transactions occurred as the stock trades well below that sale price and after the company reported a fourth-quarter earnings and revenue m…
